CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

Veronica Wendy Setiawan, Fredrick R. Schumacher, Christopher A. Haiman, Daniel O. Stram, Demetrius Albanes, David Altshuler, Göran Berglund, Julie Buring, Eugenia E. Calle, Françoise Clavel-Chapelon, David G. Cox, J. Michael Gaziano, Susan E. Hankinson, Richard B. Hayes, Brian E. Henderson, Joel N. Hirschhorn, Robert Hoover, David J. Hunter, Rudolf Kaaks, Laurence N. KolonelPeter Kraft, Jing Ma, Loïc Le Marchand, Jakob Linseisen, Eiliv Lund, Carmen Navarro, Kim Overvad, Domenico Palli, Petra H.M. Peeters, Malcolm C. Pike, Elio Riboli, Meir J. Stampfer, Michael J. Thun, Ruth C. Travis, Dimitrios Trichopoulos, Meredith Yeager, Regina G. Ziegler, Heather Spencer Feigelson, Stephen J. Chanock

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)'. Together they form a unique fingerprint.

Medicine & Life Sciences